GEICO (Spanish Group for Investigation on Ovarian Cancer) treatment guidelines in ovarian cancer 2012

Gonzalez Martin, A.; Redondo, A.; Jurado, M.; De Juan, A.; Romero, I.; Bover, I.; Del Campo, J. M.; Cervantes, A.; Garcia, Y.; Lopez-Guerrero, J. A.; Mendiola, C.; Palacios, J.; Rubio, M. J.; Poveda Velasco, A.

doi:10.1007/s12094-012-0995-8

Identifier to cite or link to this item: http://hdl.handle.net/20.500.13003/16534

View

000321112900003.pdf (427.4Kb)

Identifiers

URI: http://hdl.handle.net/20.500.13003/16534

DOI: 10.1007/s12094-012-0995-8

ISSN: 1699-048X

eISSN: 1699-3055

WOS ID: 000321112900003

Scopus EID: 2-s2.0-84879796193

PMID: 23468275

Embase PUI: L52481744

Metrics

Export

External links

Publication date

2013-07

Document type

research article

Citation

Gonzalez Martin A, Redondo A, Jurado M, De Juan A, Romero I, Bover I, et al. GEICO (Spanish Group for Investigation on Ovarian Cancer) treatment guidelines in ovarian cancer 2012. Clin Transl Oncol. 2013 Jul;15(7):509-25. Epub 2013 Mar 7.

Abstract

In 2006, under the auspices of The Spanish Research Group for Ovarian Cancer (Spanish initials GEICO), the first Treatment Guidelines in Ovarian Cancer were developed and then published in Clinical and Translational Oncology by Poveda Velasco et al. (Clin Transl Oncol 9(5):308-316, 2007). Almost 6 years have elapsed and over this time, we have seen some important developments in the treatment of ovarian cancer. Significant changes were also introduced after the GCIG-sponsored 4th Consensus Conference on Ovarian Cancer by Stuart et al. (Int J Gynecol Cancer 21:750-755, 2011). So we decided to update the treatment guidelines in ovarian cancer and, with this objective, a group of investigators of the GEICO group met in February 2012. This study summarizes the presentations, discussions and evidence that were reviewed during the meeting and during further discussions of the manuscript.